Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 1 - 1 of 1 results for "Allergan acquisition"

Market Wrap AM

AAP  |  TUESDAY, 12 MAY 2015
... shed 0.4 per cent. Pharmaceutical company Actavis rose 3.1 per cent as first-quarter earnings excluding the Allergan acquisition and other one-time costs translated into $US4.30 per share, better than the $US3.94 per share projected by analysts. LONDON ...
PAGE:
1